Alicia Langenhop and her husband faced unimaginable challenges when all three of their children inherited a rare genetic disorder, leukocyte adhesion deficiency type 1 (LAD-1), due to a DNA mutation. This disorder left them vulnerable to severe infections and had a high mortality rate. Recent advancements in Spain, particularly a groundbreaking therapy developed by researchers at the Center for Energy, Environmental and Technological Research (CIEMAT), have successfully treated these children, allowing them to lead normal lives. The remarkable results of this therapy were published in The New England Journal of Medicine, marking a significant milestone in genetic research.
The astonishing results were published on April 30 in The New England Journal of Medicine, demonstrating a revolutionary therapy that changed the lives of children with a rare genetic disorder.
Alicia and her husband, carriers of a rare mutation, faced the grim reality of all three children inheriting a disease with a 25% chance, reflecting an extraordinary turn of events in genetic health.
Collection
[
|
...
]